Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine administered either concomitantly or singly in participants 65 years of age and older previously vaccinated with a 2-dose schedule of Moderna COVID-19 Vaccine

Trial Identifier: QHD00028
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: July 2021
Primary Completion Date: February 2022
Study Completion Date: February 2022
Condition: Healthy Volunteers; Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Arizona Glendale, Arizona, United States, 85306
United States, California San Diego, California, United States, 92108
United States, California Vista, California, United States, 92083
United States, Colorado Centennial, Colorado, United States, 80112
United States, Illinois Peoria, Illinois, United States, 61614
United States, Texas Austin, Texas, United States, 78705